Cogent Biosciences COGT Stock
Cogent Biosciences Price Chart
Cogent Biosciences COGT Financial and Trading Overview
| Cogent Biosciences stock price | 6.51 USD |
| Previous Close | 12.85 USD |
| Open | 12.97 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 12.47 - 13.01 USD |
| 52 Week Range | 7.79 - 18.07 USD |
| Volume | 795.13K USD |
| Avg. Volume | 728.96K USD |
| Market Cap | 1.05B USD |
| Beta (5Y Monthly) | -0.402311 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.42 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 22.22 USD |
COGT Valuation Measures
| Enterprise Value | 773.17M USD |
| Trailing P/E | N/A |
| Forward P/E | -6.0625 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 5.5477343 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -4.883 |
Trading Information
Cogent Biosciences Stock Price History
| Beta (5Y Monthly) | -0.402311 |
| 52-Week Change | 37.21% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 18.07 USD |
| 52 Week Low | 7.79 USD |
| 50-Day Moving Average | 11.42 USD |
| 200-Day Moving Average | 12.64 USD |
COGT Share Statistics
| Avg. Volume (3 month) | 728.96K USD |
| Avg. Daily Volume (10-Days) | 1.11M USD |
| Shares Outstanding | 83.45M |
| Float | 57.63M |
| Short Ratio | 7.22 |
| % Held by Insiders | 0.0020% |
| % Held by Institutions | 109.46% |
| Shares Short | 4.64M |
| Short % of Float | 6.80% |
| Short % of Shares Outstanding | 6.54% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -42.45% |
| Return on Equity (ttm) | -72.039% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -121627000 USD |
| EBITDA | -158356000 USD |
| Net Income Avi to Common (ttm) | -148194000 USD |
| Diluted EPS (ttm) | -2.37 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 220.26M USD |
| Total Cash Per Share (mrq) | 3.11 USD |
| Total Debt (mrq) | 19.46M USD |
| Total Debt/Equity (mrq) | 8.71 USD |
| Current Ratio (mrq) | 10.714 |
| Book Value Per Share (mrq) | 2.273 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -129821000 USD |
| Levered Free Cash Flow (ttm) | -78858248 USD |
Profile of Cogent Biosciences
| Country | United States |
| State | MA |
| City | Waltham |
| Address | 275 Wyman Street |
| ZIP | 02451 |
| Phone | 617 945 5576 |
| Website | https://www.cogentbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 138 |
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target exon 17 mutations found within the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Q&A For Cogent Biosciences Stock
What is a current COGT stock price?
Cogent Biosciences COGT stock price today per share is 6.51 USD.
How to purchase Cogent Biosciences stock?
You can buy COGT shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cogent Biosciences?
The stock symbol or ticker of Cogent Biosciences is COGT.
Which industry does the Cogent Biosciences company belong to?
The Cogent Biosciences industry is Biotechnology.
How many shares does Cogent Biosciences have in circulation?
The max supply of Cogent Biosciences shares is 95.61M.
What is Cogent Biosciences Price to Earnings Ratio (PE Ratio)?
Cogent Biosciences PE Ratio is now.
What was Cogent Biosciences earnings per share over the trailing 12 months (TTM)?
Cogent Biosciences EPS is -2.42 USD over the trailing 12 months.
Which sector does the Cogent Biosciences company belong to?
The Cogent Biosciences sector is Healthcare.
Cogent Biosciences COGT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}